These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9529402)

  • 1. Israel's patent law criticised.
    Siegel-Itzkovich J
    BMJ; 1998 Mar; 316(7133):725. PubMed ID: 9529402
    [No Abstract]   [Full Text] [Related]  

  • 2. Engineered in India--patent law 2.0.
    Castellani JJ
    N Engl J Med; 2013 Nov; 369(22):2163. PubMed ID: 24283241
    [No Abstract]   [Full Text] [Related]  

  • 3. Intellectual property law in Israel, and US and European objections: Market exclusivity vs. data exclusivity.
    Morag-Sela T; Cohn I; Kowalski TJ; Jarecki-Black J; Clyde-Watson Z
    Nat Biotechnol; 2004 Dec; 22(12):1591-2. PubMed ID: 15583670
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes to India's patent law may deny cheap drugs to millions.
    Mudur G
    BMJ; 2005 Mar; 330(7493):692. PubMed ID: 15790640
    [No Abstract]   [Full Text] [Related]  

  • 5. Engineered in India--patent law 2.0.
    Kapczynski A
    N Engl J Med; 2013 Aug; 369(6):497-9. PubMed ID: 23862973
    [No Abstract]   [Full Text] [Related]  

  • 6. How Patent Troll Legislation Can Increase Timely Access to Generic Drugs.
    Treasure CL; Kesselheim AS
    JAMA Intern Med; 2016 Jun; 176(6):729-30. PubMed ID: 27183456
    [No Abstract]   [Full Text] [Related]  

  • 7. Patent. Battle lines are drawn over generic AIDS drug.
    AIDS Policy Law; 2005 Aug; 20(16):6. PubMed ID: 16161208
    [No Abstract]   [Full Text] [Related]  

  • 8. Preliminary injunctions in generic and branded patent litigation.
    Cohen S; England P
    Expert Opin Ther Pat; 2013 Sep; 23(9):1083-6. PubMed ID: 23855903
    [No Abstract]   [Full Text] [Related]  

  • 9. Patent infringement. Generic HIV drugmaker's patent claim is time-barred.
    AIDS Policy Law; 2003 Aug; 18(16):6. PubMed ID: 14626916
    [No Abstract]   [Full Text] [Related]  

  • 10. India's new patent laws may still hurt generic drug supplies.
    Chatterjee P
    Lancet; 2005 Apr 16-22; 365(9468):1378. PubMed ID: 15841559
    [No Abstract]   [Full Text] [Related]  

  • 11. Legal challenge to India's patent laws threatens access to generic drugs, says charity.
    Moszynski P
    BMJ; 2011 Sep; 343():d5753. PubMed ID: 21908529
    [No Abstract]   [Full Text] [Related]  

  • 12. European Commission targets drug firms over illegal patent protection.
    Watson R
    BMJ; 2010 Jan; 340():c268. PubMed ID: 20080819
    [No Abstract]   [Full Text] [Related]  

  • 13. Supreme Court rules against Teva in Copaxone® patent fight.
    Sklan A
    Pharm Pat Anal; 2014 Jul; 3(4):350-1. PubMed ID: 26900611
    [No Abstract]   [Full Text] [Related]  

  • 14. Special patent provisions for pharmaceuticals: have they outlived their usefulness? A political, legislative and legal history of U.S. law and observations for the future.
    Engelberg AB
    Spec Law Dig Health Care Law; 2000 Sep; (258):9-48. PubMed ID: 11184791
    [No Abstract]   [Full Text] [Related]  

  • 15. Novartis faces growing pressure to drop patent case against Indian government.
    Hargreaves S
    BMJ; 2007 Feb; 334(7590):383. PubMed ID: 17322224
    [No Abstract]   [Full Text] [Related]  

  • 16. Taking TRIPS to India--Novartis, patent law, and access to medicines.
    Mueller JM
    N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
    [No Abstract]   [Full Text] [Related]  

  • 17. High Court strikes down Merck's patent on alendronate.
    Dyer O
    BMJ; 2003 Feb; 326(7383):243. PubMed ID: 12560269
    [No Abstract]   [Full Text] [Related]  

  • 18. Canada to change patent law to allow export of cheap drugs.
    Kondro W
    Lancet; 2003 Oct; 362(9392):1290. PubMed ID: 14577437
    [No Abstract]   [Full Text] [Related]  

  • 19. Patent watch.
    Harrison C
    Nat Rev Drug Discov; 2013 Jan; 12(1):14-5. PubMed ID: 23274462
    [No Abstract]   [Full Text] [Related]  

  • 20. Better protection for patentees: preliminary injunctions in the EU for pharmaceutical patent matters.
    von Falck A; Gundt M
    Pharm Pat Anal; 2013 May; 2(3):291-3. PubMed ID: 24237054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.